Modelled DT Structure
Method: homology modeling
Template PDB: 4XPB_A
Identity: 58.333%
Minimized Score: -1509.924 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0452 | ||||
| Gene Name | SLC6A2 | ||||
| Protein Name | Sodium-dependent noradrenaline transporter | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 4XPB_A Identity: 58.333% Minimized Score: -1509.924 kcal/mol Detail: Structure Info |
||||
| Synonyms | NET; NET1; Norepinephrine transporter; SLC6A2; Solute carrier family 6 member 2 | ||||
| DT Family | Neurotransmitter:Sodium Symporter (NSS) Family ; | ||||
| Function | This transporter is amine transporter. Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals. | ||||
| Disease(s) | Neurogenic shock [ICD-11: MG40.Y] | ||||
| Endogenous Substrate(s) | 1-methyl-4-tetrahydropyridinium; Na+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(α) Microbiota Influence of This DT |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
(γ) Outward/inward-facing Conformation |
|||||
|
(δ) Xenobiotics-regulated Structural Variability |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(α) Genetic Polymorphisms of This DT |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Amphetamine
|
Approved | Drug Info | Attention deficit hyperactivity disorder | 6A05 | [1] |
|
Norepinephrine
|
Approved | Drug Info | Septic shock | 1G41 | [2] |
|
Drug-DT Affinity Assessed by Cell Line |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Norepinephrine | Approved | Drug Info | Monkey kidney fibroblast-like cell (COS)1-NET | Km = 690 microM | [3] |
| References | |||||
| 1 | Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol Sci. 2015 Jan;36(1):41-50. | ||||
| 2 | Chronic depolarization stimulates norepinephrine transporter expression via catecholamines. J Neurochem. 2006 May;97(4):1044-51. | ||||
| 3 | chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model. J Biol Chem. 2007 Jun 15;282(24):17837-44. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.